Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound

• Status: Terminated
• Trial end date: 2020-08-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of administration being evaluated are topical, nebulized and atomized.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Milton S. Hershey Medical Center
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Diagnosis of mediastinal and/or hilar lymphadenopathy requiring endobronchial ultrasound evaluation and transbronchial needle aspiration.

• Diagnosis of pulmonary disease requiring flexible bronchoscopy

• Greater than 18 years of age.

Exclusion Criteria:

• Any intervention beyond flexible bronchoscopy and endobronchial ultrasound

• Inability to tolerate bronchoscopy.

• Patients that receive paralytics.

• Patients with neuromuscular diseases.

• Inability to consent for procedures.

• Allergies to lidocaine or any other drugs used in protocol.

• Existing renal insufficiency or liver disease